Who has invested in Pionyr Immunotherapeutics?

OrbiMed, NEA, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital are named among the investors backing Pionyr Immunotherapeutics.

Pionyr Immunotherapeutics Funding: $78M Raised, Series B

Pionyr Immunotherapeutics funding overview

Pionyr Immunotherapeutics is based in San Francisco. Pionyr Immunotherapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2017. The round record for Pionyr Immunotherapeutics runs through 2017; nothing later has been disclosed. Investors on record include OrbiMed, NEA, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Pionyr Immunotherapeutics at a glance

Total raised: $78M
Latest round: Series B
Latest round date: December 2017
Headquarters: San Francisco
Notable investors: OrbiMed, NEA, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital, Mission Bay Capital, Osage University Partners

Frequently asked about Pionyr Immunotherapeutics funding

How much has Pionyr Immunotherapeutics raised?: Pionyr Immunotherapeutics has raised $78M in total disclosed funding across the rounds on record.
Who has invested in Pionyr Immunotherapeutics?: OrbiMed, NEA, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital are named among the investors backing Pionyr Immunotherapeutics.
What was the latest Pionyr Immunotherapeutics funding round?: The most recent disclosed round is a Series B, announced in December 2017.
Where is Pionyr Immunotherapeutics based?: Pionyr Immunotherapeutics is based in San Francisco.
When did Pionyr Immunotherapeutics last raise?: The last disclosed Pionyr Immunotherapeutics round closed in December 2017 at Series B.

Pionyr Immunotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.

Pionyr Immunotherapeutics Funding: $78M Raised, Series B

Pionyr Immunotherapeutics funding overview

Pionyr Immunotherapeutics at a glance

Frequently asked about Pionyr Immunotherapeutics funding

Companies related to Pionyr Immunotherapeutics (36)

Browse related funding lists (7)